Clostridium perfringens TpeL glycosylates the Rac and Ras subfamily proteins

Infection and Immunity

Volumn 79, Issue 2, 2011, Pages 905-910

  Nagahama, Masahiro ^a   Ohkubo, Akiko ^a   Oda, Masataka ^a   Kobayashi, Keiko ^a   Amimoto, Katsuhiko ^b   Miyamoto, Kazuaki ^c   Sakurai, Jun ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b Kyoto Biken Laboratories   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIAL TOXIN; CLOSTRIDIUM PERFRINGENS TPEL; GLYCOSYLATED PROTEIN; GUANOSINE TRIPHOSPHATASE; RAC1 PROTEIN; RAL PROTEIN; RAP1 PROTEIN; RAS PROTEIN; RECOMBINANT PROTEIN; STREPTOLYSIN O; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCOSE; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CLOSTRIDIUM PERFRINGENS; CYTOTOXICITY; ENZYME MODIFICATION; GLYCOSYLATION; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; VERO CELL;

ANIMALS; BACTERIAL TOXINS; CERCOPITHECUS AETHIOPS; CLOSTRIDIUM PERFRINGENS; CYTOTOXINS; GLYCOSYLATION; GTP PHOSPHOHYDROLASES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; RAS PROTEINS; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; VERO CELLS;

EID: 79251471404     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01019-10     Document Type: Article

References (25)

1. Amimoto, K., T. Noro, E. Oishi, and M. Shimizu. 2007. A novel toxin homologous to large clostridial cytotoxins found in culture supernatant of Clostridium perfringens type C. Microbiology 153:1198-1206.
2. Belyi, Y., and K. Aktories. 2010. Bacterial toxin and effector glycosyltransferases. Biochim. Biophys. Acta 1800:134-143.
3. Bosco, E. E., J. C. Mulloy, and Y. Zheng. 2009. Rac1 GTPase: a "Rac" of all trades. Cell. Mol. Life Sci. 66:370-374.
4. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
5. Busch, C., et al. 1998. A common motif of eukaryotic glycosyltransferases is essential for the enzyme activity of large clostridial cytotoxins. J. Biol. Chem. 273:19566-19572.
6. Busch, C., F. Hofmann, R. Gerhard, and K. Aktories. 2000. Involvement of a conserved tryptophan residue in the UDP-glucose binding of large clostridial cytotoxin glycosyltransferases. J. Biol. Chem. 275:13228-13234.
7. Egerer, M., T. Giesemann, C. Herrmann, and K. Aktories. 2009. Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate. J. Biol. Chem. 284:3389-3395.
8. Genth, H., K. Aktories, and I. Just. 1999. Monoglucosylation of RhoA at threonine 37 blocks cytosol-membrane cycling. J. Biol. Chem. 274:29050-29056.
9. Genth, H., et al. 2006. Cellular stability of Rho-GTPases glucosylated by Clostridium difficile toxin B. FEBS Lett. 580:3565-3569.
10. Halabi-Cabezon, I., et al. 2008. Prevention of the cytopathic effect induced by Clostridium difficile toxin B by active Rac1. FEBS Lett. 582:3751-3756.
11. Jank, T., D. J. Reinert, T. Giesemann, G. E. Schulz, and K. Aktories. 2005. Change of the donor substrate specificity of Clostridium difficile toxin B by site-directed mutagenesis. J. Biol. Chem. 280:37833-37838.
12. Jank, T., T. Giesemann, and K. Aktories. 2007. Clostridium difficile glucosyltransferase toxin B-essential amino acids for substrate binding. J. Biol. Chem. 282:35222-35231.
13. Jank, T., T. Giesemann, and K. Aktories. 2007. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. Glycobiology 17:15-22.
14. Kato, H., et al. 1998. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J. Clin. Microbiol. 36:2178-2182.
15. Nagahama, M., K. Nagayasu, K. Kobayashi, and J. Sakurai. 2002. Binding component of Clostridium perfringens iota-toxin induces endocytosis in Vero cells. Infect. Immun. 70:1909-1914.
16. Nagahama, M., S. Hayashi, S. Morimitsu, and J. Sakurai. 2003. Biological activities and pore formation of Clostridium perfringens beta toxin in HL 60 cells. J. Biol. Chem. 278:36934-36941.
17. Popoff, M. R. 1987. Purification and characterization of Clostridium sordellii lethal toxin and cross-reactivity with Clostridium difficile cytotoxin. Infect. Immun. 55:35-43.
18. Reineke, J., et al. 2007. Autocatalytic cleavage of Clostridium difficile toxin B. Nature 446:415-419.
19. Reinert, D. J., T. Jank, K. Aktories, and G. E. Schulz. 2005. Structural basis for the function of Clostridium difficile toxin B. J. Mol. Biol. 351:973-981.
20. Sakurai, J., and M. Nagahama. 2006. Clostridium perfringens beta-toxin: characterization and action. Toxin Rev. 25:89-108.
21. Selzer, J., et al. 1996. Clostridium novyi alpha-toxin-catalyzed incorporation of GlcNAc into Rho subfamily proteins. J. Biol. Chem. 271:25173-25178.
22. Smedley, J. G., III, D. J. Fisher, S. Sayeed, G. Chakrabarti, and B. A. McClane. 2004. The enteric toxins of Clostridium perfringens. Rev. Physiol. Biochem. Pharmacol. 152:183-204.
23. Tweten, R. K. 2001. Clostridium perfringens beta toxin and Clostridium septicum alpha toxin: their mechanisms and possible role in pathogenesis. Vet. Microbiol. 82:1-9.
24. Voth, D. E., and J. D. Ballard. 2005. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18:247-263.
25. Walev, I., et al. 2001. Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin O. Proc. Natl. Acad. Sci. U. S. A. 98:3185-3190.